Boston Scientific Corp/ US1011371077 /
| 2024-04-26 9:59:59 PM | Chg. -0.16 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 73.12USD | -0.22% | 289,614 Turnover: 21.22 mill. |
-Bid Size: - | -Ask Size: - | 107.38 bill.USD | - | 67.77 |
Assets
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,697 | 1,782 | 2,079 | 2,084 | 2,252 | ||||||
| Intangible Assets | 5,837 | 6,372 | 7,886 | 5,917 | 6,121 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 15,220 | 16,996 | 25,866 | 24,083 | 25,912 | ||||||
| Inventories | 1,078 | 1,166 | 1,579 | 1,351 | 1,610 | ||||||
| Accounts Receivable | 1,548 | 1,608 | 1,828 | 1,531 | 1,778 | ||||||
| Cash and Cash Equivalents | 188 | 146 | 217 | 1,734 | 1,925 | ||||||
| Current Assets | 3,822 | 4,003 | 4,699 | 6,694 | 6,317 | ||||||
| Total Assets | 19,042 | 20,999 | 30,565 | 30,777 | 32,229 | ||||||
Liabilities
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 530 | 349 | 542 | 513 | 794 | ||||||
| Long-term debt | 3,815 | 4,803 | 8,592 | 9,130 | 8,804 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 191 | 328 | 595 | 330 | 310 | ||||||
| Liabilities | 12,030 | 12,273 | 16,688 | 15,451 | 15,607 | ||||||
| Share Capital | 16 | 16 | 16 | 17 | 17 | ||||||
| Total Equity | 7,012 | 8,726 | 13,877 | 15,326 | 16,622 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 19,042 | 20,999 | 30,565 | 30,777 | 32,229 | ||||||
Income Statement
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 9,048 | 9,823 | 10,735 | 9,913 | 11,888 | ||||||
| Depreciation (total) | 565 | 599 | 699 | 789 | 741 | ||||||
| Operating Result | 1,285 | 1,506 | 1,518 | -80 | 1,199 | ||||||
| Interest Income | -229 | -241 | -473 | -361 | -341 | ||||||
| Income Before Taxes | 933 | 1,422 | 687 | -79 | 1,076 | ||||||
| Income Taxes | 828 | -249 | -4,013 | 2 | 36 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 104 | 1,671 | 4,700 | -115 | 985 | ||||||
Per Share
Cash Flow
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1,426 | 310 | 1,836 | 1,508 | 1,870 | ||||||
| Cash Flow from Investing Activities | -1,010 | -1,921 | -5,041 | -411 | -1,597 | ||||||
| Cash Flow from Financing | 110 | 1,432 | 2,973 | 293 | -95 | ||||||
| Decrease / Increase in Cash | 530 | -188 | -222 | 1,388 | 173 | ||||||
| Employees | 29,000 | 32,000 | 36,000 | 38,000 | 41,000 | ||||||
